Deqi Guo

This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Adolor Corporation, Eli Lilly and Company, Vertex Pharmaceuticals, Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deqi Guo. Retrieved from https://idiyas.com/inventor/deqi-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 9)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 213(Granted Patents)

Location History:

Edmonton, CA (1999)
Phoenixville, PA (US) (2000 - 2002)
Carmel, IN (US) (2004 - 2023)

Company Filing History:

Eli Lilly and Company

patents

3 out of 1,169

Vertex Pharmaceuticals, Inc.

patents

4. 2 out of 21

Synphar Laboratories, Inc.

patents

5. 1 out of 4

Naeja Pharmaceutical Inc.

patents

6. 1 out of 1

Synphar Laboraties, Inc.

patent

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

KRas Inhibitors

EZH2 Inhibitors

Peptidomimetic Protease Inhibitors

Kappa Agonist Compounds

Pharmaceutical Formulations

Cysteine Protease Inhibitors

Azetidin-2-One Derivatives

Penam Derivatives

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723053 - KRas inhibitors (2026-09-01),

2. 12351591 - KRas inhibitors (2025-07-08),

3. 11731984 - KRas G12C inhibitors (2023-08-22),

4. 9718838 - Inhibitors of EZH2 (2017-08-01),

5. 9527837 - Inhibitors of EZH2 (2016-12-27),

6. 8529882 - Peptidomimetic protease inhibitors (2013-09-10),

7. 8252923 - Peptidomimetic protease inhibitors (2012-08-28),

8. 7820671 - Peptidomimetic protease inhibitors (2010-10-26),

9. 6750216 - Kappa agonist compounds and pharmaceutical formulations thereof (2004-06-15),

10. 6492351 - Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2002-12-10),

11. 6486165 - Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2002-11-26),

12. 6476063 - Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2002-11-05),

13. 6391910 - Kappa agonist compounds and pharmaceutical formulations thereof (2002-05-21),

14. 6303611 - Kappa agonist compounds and pharmaceutical formulations thereof (2001-10-16),

15. 6239154 - Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith (2001-05-29),

Title: The Innovative Journey of Deqi Guo

Introduction: Deqi Guo, a talented inventor based in Carmel, IN (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Deqi Guo holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Deqi Guo has successfully brought several cutting-edge inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Deqi Guo has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market, demonstrating his commitment to innovation and collaboration.

Conclusion: Deqi Guo's relentless pursuit of innovation and his remarkable contributions to the world of technology make him a true visionary in the field of inventions. His work continues to inspire and shape the future of various industries, leaving a lasting impact on society.

Profile summary based on public USPTO records.